Clinical trial

Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain…

NCT00280748 · UNC Lineberger Comprehensive Cancer Center, Other · Terminated

Key facts

NCT number NCT00280748
Title Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
Official title A Phase II Study of Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Concurrent Whole Brain Radiation Therapy and Pemetrexed
Acronym NRR
Lead sponsor UNC Lineberger Comprehensive Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Lung Cancer, Metastatic Cancer
Intervention type Drug, Radiation
Interventions pemetrexed disodium, radiation therapy
Enrollment 10
Start date May 1, 2005
Primary completion Dec 1, 2008
Completion Apr 1, 2009
First posted Jan 23, 2006
Last update posted Jun 23, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies